Akums Drugs and Pharmaceuticals Limited (BOM:544222)
814.70
+14.10 (1.76%)
At close: Oct 6, 2026
BOM:544222 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, BOM:544222 stock has a consensus rating of "Strong Buy" and an average price target of ₹863.33. The average 1-year stock price forecast is 5.97% higher than the current stock price, while the lowest is ₹850.00 (+4.33%) and the highest is ₹880.00 (+8.02%).
Price Target: ₹863.33 (+5.97%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BOM:544222 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
50.25B
from 43.61B
Increased by 15.21%
Revenue Next Year
57.80B
from 50.25B
Increased by 15.04%
EPS This Year
27.23
from 17.55
Increased by 55.17%
EPS Next Year
34.13
from 27.23
Increased by 25.35%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.